Wilms Tumor Treatment Market, Size, Share, Growth, Trends, Insight and Industry Forecast, 2021-2028

SKU: DMAG3391 | Last Updated On: May 29 2021 | No. of Pages: 180 | Available Formats

> Global Wilms Tumor Treatment Market to reach a high CAGR By 2028: DataM Intelligence

Global Wilms Tumor Treatment Market is segmented By Treatment type (Surgery, Chemotherapy, Radiation therapy, Others), By End-users (Hospitals, Surgical Centers, Cancer research institutes, Others), By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2021-2028

Market Overview

The Global Wilms Tumor Treatment Market is expected to grow at a CAGR during the forecasting period (2021-2028).

Wilms tumor, also known as nephroblastoma, is a rare type of kidney cancer that primarily affects children. It's the most common cancer of the kidneys in children. Wilms' tumor most often affects children ages 3 to 4 and becomes much less common after age 5. About 9 of 10 kidney cancers in children are Wilms tumors. It most often occurs just in one kidney, though it can sometimes be found in both kidneys at the same time. Some of the common symptoms seen in children suffering from this disease are fever, abdominal pain and swelling, and blood loss during urination. In the last few years, the diagnosis and treatment of the Wilms tumor are vastly improved. It is also helping majorly in the prognosis for children suffering from this disease. If appropriate treatment and care are provided, the prognosis of the tumor is excellent. The survival rate for children's disease has improved to 80%–90%. The treatment for Wilms tumor is surgery, chemotherapy, and radiotherapy.

Source: DataM Intelligence Analysis (2019)

Market Dynamics

The global Wilms Tumor Treatment market growth is driven by the growing new born births per year, Rise in R&D activities, increasing advancements in novel therapies and diagnostic products are the major factors driving the market.

Increasing advancements in novel therapies and diagnostic products, is expected to drive the market during the forecast period.

Proton beam radiation is a newer approach. Proton beam radiation uses radioactive particles that travel only a certain distance before releasing most of their energy. For instance, to study the Pencil Beam Scanning Proton Beam Radiation Therapy in Patients with Wilms Tumors by Children's Hospital of Philadelphia is under Early Phase I trials is expected to complete by 2023, which is expected to increase the demand of the market.

Novel diagnostic products are increasing also the demand of the market. For instance, Federal Research Institute of Pediatric Hematology, Oncology and Immunology conducting the trial on Diagnostic test named MRI DWI sequence (ADC values) Diffusion-weighted Images as an Additional Method for Diagnosing Histological Types of Nephroblastoma (Wilms tumor) in Children.

High cost of Treatment, is likely to hinder the market growth.

The pricing for Wilms tumor treatment includes surgery, chemotherapy and radiation therapy. Surgical cost can range from Rs.50,000 to Rs.1,00,000. Chemotherapy and radiation therapy start from Rs.30,000 and go up to Rs.1,00,000 in India. These factors are restricting the market growth.

COVID-19 Impact Analysis

The COVID-19 pandemic has negatively impacted healthcare systems globally and on the market growth. According to the Centers for Disease Control and Prevention (CDC) and many medical professional organizations recommended that cancer screening and other health prevention services, along with elective surgeries, be postponed unless the risks outweighed the benefits and secure the hospital infrastructure for the treatment of COVID-19 patients. Thus, the COVID-19 pandemic has impacted the On-going clinical trials too. However, the situation is expected to improve gradually.

Segment Analysis

Based on Treatment method, the global Wilms Tumor Treatment market is segmented into Surgery, Chemotherapy, Radiation Therapy.

The treatment for Wilms tumor is based mainly on the stage of cancer and whether its histology (how it looks under the microscope) is favorable or anaplastic. Other factors can influence the treatment as well, including the child’s age, If the tumor cells have specific chromosome changes, the size of the primary tumor. In the United States, doctors mostly prefer to use surgery as the first treatment in most cases and then give chemotherapy (and possibly radiation therapy) afterward. In Europe, doctors prefer to start chemotherapy before surgery. The results from these two approaches seem to be about the same.

The Surgery segment, along with Chemotherapy, is expected to boost the growth of the Wilms Tumor Treatment market. 

Currently, Surgery and Chemotherapy dominate the market and are anticipated to continue this trend throughout the forecasting period. Surgery is the main treatment for nearly all children suffering from Wilms tumors. The main goal of surgery is to remove the entire Wilms tumor in one piece, if possible. It keeps the cancer cells from spreading in the abdomen (belly), and Chemotherapy is the use of drugs to treat cancer. These drugs enter the blood and reach all areas of the body, making this treatment useful for cancer that has spread or might have spread beyond the kidney. Most of the children with Wilms tumors will get chemo at some point during their treatment. A combination of chemo drugs is used to treat children with Wilms tumors are Actinomycin D (dactinomycin), Vincristine. For tumors at more advanced stages, those with anaplastic histology, or tumors that recur (come back) after treatment, other drugs might also be used, such as Doxorubicin (Adriamycin), Cyclophosphamide, Etoposide, Irinotecan, Carboplatin. For instance, A study of combination chemotherapy for patients with newly diagnosed Diffuse Anaplastic Wilms Tumors (DAWT) and Relapsed Favorable Histology Wilms Tumors (FHWT) is under Phase 2 clinical trials conducted by Children's Oncology Group and National Cancer Institute (NCI).

Based on End-User, the global Wilms Tumor Treatment market   is segmented into Hospitals, Cancer Research centers, Surgical centers, others.

Due to the growing patient population, the hospitals segment held the largest market share. This is mainly owing to increasing number of patients suffering from conditions which are treated in hospitals equipped with advanced infrastructure and adequate facilities. Moreover, growing number of hospitals along with adequate reimbursement policies is also contributing to the growth of this segment. Also the medications can only be administrated by intravenously and surgery is done under supervision of medical practioners at these locations.

 

Source: DataM Intelligence Analysis (2019)

Geographical Analysis

North America served the largest share of the market due to the increasing prevalence of Wilms tumor cases. According to the American Cancer Society, each year, about 500 to 600 new cases of Wilms tumor are diagnosed in the United States. About 5% of all cancers in children are Wilms tumors. The existence of a highly developed healthcare system, the high degree of acceptance by medical practitioners of novel chemotherapy and targeted therapy methods, the total availability of advanced diagnostic tools, and many companies are developing oncology products. For instance, Acrotech Biopharma LLC in Collaboration with National Cancer Institute (NCI) conducting Phase I Trial to Evaluate the Safety, Activity and Pharmacokinetics of Marqibo (Registered Trademark) (Vincristine Sulfate Liposomes Injection) in Children and Adolescents with Wilms Tumor.

The Asia Pacific is expected to be the fastest-growing market over the forecast period owing to increasing prevalence rate, increasing focus on preventive care, and government initiatives promoting technological innovations. 

Source: DataM Intelligence Analysis (2019)

Competitive Landscape 

The global Wilms Tumor Treatment market is quite competitive with some key competitors like Bayer HealthCare LLC, F. Hoffmann-La Roche Ltd., Pfizer Inc., Sanofi Pasteur Inc., Merck & Co. Inc. and MediLexicon International Ltd, Bristol-Myers Squibb, APOTEX Inc, Exelixis Inc, NanoSmart Pharmaceuticals Inc. The key players are adopting various growth strategies such as product launch, acquisitions and investments in multiple sectors. 

For instance, according to clinicaltrials.gov; Bayer conducting a Multi-center, Open-label, Non-randomized, Phase I Dose Escalation Study of Regorafenib (BAY 73-4506) in Pediatric Subjects with Solid Malignant Tumors That Are Recurrent or Refractory to Standard Therapy.

Hoffmann-La Roche Ltd

Company Overview: Roche was founded in 1896 in Basel, Switzerland. It creates innovative medicines and diagnostic tests that help millions of patients globally. Roche was one of the first companies to bring targeted treatments to patients. With our combined strength in pharmaceuticals and diagnostics, we are better equipped than any other company to drive personalized healthcare further. Two-thirds of our Research and Development projects are being developed with companion diagnostics. Genentech become a member of the Roche Group in March of 2009.

Product Portfolio: The company portfolio includes Oncology, Neurology, Endocrinology, Infectious diseases and others.

Why Purchase the Report?

  • Visualize the composition of the Wilms Tumor Treatment Market segmentation by Treatment type, End-users, and region highlighting the key commercial assets and players.
  • Identify commercial opportunities in Wilms Tumor Treatment Market by analyzing trends and co-development deals. 
  • Excel data sheet with thousands of data points of Wilms Tumor Treatment Market - level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study. 
  • Product mapping in excel for the key product of all major market players

The global Wilms Tumor Treatment Market report would provide an access to an approx. 53 market data table, 47 figures and 240 pages. 

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Related Topic’s

Solid Tumor Therapeutics Market

Cancer Tumor Profiling Market

Circulating Tumor Cells (CTC) Market

Neuroendocrine Tumor Treatment Market

Table of Contents

  1. Global Wilms Tumor Treatment Market Methodology and Scope

    1. Research Methodology
    2. Research Objective and Scope of the Report
  2. Global Wilms Tumor Treatment Market – Market Definition and Overview

  3. Global Wilms Tumor Treatment Market– Executive Summary

    1. Market snippet by Treatment Type
    2. Market Snippet by End-users
    3. Market Snippet by Region
  4. Global Wilms Tumor Treatment Market – Market Dynamics
    1. Market Impacting Factors
      1. Drivers
        1. Increasing advancements in novel therapies and diagnostic products,
      2. Restraints:
        1. High cost of Treatment
      3. Opportunity
      4. Impact Analysis
  5. Global Wilms Tumor Treatment Market – Industry Analysis 

    1. Porter's Five Forces Analysis 
    2. Supply Chain Analysis
    3. Pricing Analysis
    4. Regulatory Analysis
    5. Reimbursement Analysis
    6. Unmet Needs
  6. Global Wilms Tumor Treatment Market – COVID-19 Analysis
    1. Analysis of Covid-19 on the Market
      1. Before COVID-19 Market Scenario
      2. Present COVID-19 Market Scenario
      3. After COVID-19 or Future Scenario
    2. Pricing Dynamics Amid Covid-19
    3. Demand-Supply Spectrum
    4. Government Initiatives Related to the Market During Pandemic
    5. Manufacturers Strategic Initiatives
    6. Conclusion 
  7. Global Wilms Tumor Treatment Market – By Treatment type

    1. Introduction
    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment type
    3. Market Attractiveness Index, By Treatment type
      1. Surgery*
        1. Introduction
        2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
      2. Chemotherapy
      3. Radiation therapy
      4. Others
  8. Global Wilms Tumor Treatment Market – By End-users

    1. Introduction
    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-users segment
    3. Market Attractiveness Index, By End-users Segment
      1. Hospitals*
        1. Introduction
        2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
      2. Surgical Centers
      3. Cancer research institutes 
      4. Others
  9. Global Wilms Tumor Treatment Market – By Region

    1. Introduction 
    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    3. Market Attractiveness Index, By Region
    4. North America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End -users
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. U.S.
        2. Canada
        3. Mexico
    5. Europe
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End -users
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Germany
        2. U.K.
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
    6. South America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End -users
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Brazil
        2. Argentina
        3. Rest of South America
    7. Asia Pacific
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-users
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. China
        2. India
        3. Japan
        4. Australia
        5. Rest of Asia Pacific
    8. Middle East and Africa
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  10. Global Wilms Tumor Treatment Market – Competitive Landscape

    1. Competitive Scenario
    2. Market Positioning/Share Analysis
    3. Mergers and Acquisitions Analysis
  11. Global Wilms Tumor Treatment Market - Company Profiles

    1. F. Hoffmann-La Roche Ltd*
      1. Company Overview
      2. Product Portfolio and Description
      3. Key Highlights
      4. Financial Overview
    2. Bayer HealthCare LLC,
    3. Pfizer Inc., 
    4. Sanofi Pasteur Inc., 
    5. Merck & Co. Inc.  
    6. MediLexicon International Ltd, 
    7. Bristol-Myers Squibb, 
    8. APOTEX Inc, 
    9. Exelixis Inc, 
    10. NanoSmart Pharmaceuticals Inc.(*LIST NOT EXHAUSTIVE)
  12. Global Wilms Tumor Treatment Market – Premium Insights

  13. Global Wilms Tumor Treatment Market – DataM 

    1. Appendix
    2. About Us and Services
    3. Contact Us

List of Tables & Figures

List of Tables 

Table 1 Global Wilms Tumor Treatment Market Value, By Treatment Type, 2019,2023 & 2027 ($ Million)

Table 2 Global Wilms Tumor Treatment Market Value, By End-Users, 2019,2023 & 2027 ($ Million)

Table 3 Global Wilms Tumor Treatment Market Value, By Region, 2019,2023 & 2027 ($ Million)

Table 4 Global Wilms Tumor Treatment Market Value, By Treatment Type, 2019,2023 & 2027 ($ Million)

Table 5 Global Wilms Tumor Treatment Market Value, By Treatment Type, 2018-2027 ($ Million)

Table 6 Global Wilms Tumor Treatment Market Value, By End-Users, 2019,2023 & 2027 ($ Million)

Table 7 Global Wilms Tumor Treatment Market Value, By End-Users, 2018-2027 ($ Million)

Table 8 Global Wilms Tumor Treatment Market Value, By Region, 2019,2023 & 2027 ($ Million)

Table 9 Global Wilms Tumor Treatment Market Value, By Region, 2018-2027 ($ Million)

Table 10 North America Wilms Tumor Treatment Market Value, By Treatment Type, 2018-2027 ($ Million)

Table 11 North America Wilms Tumor Treatment Market Value, By End-Users, 2018-2027 ($ Million)

Table 12 North America Wilms Tumor Treatment Market Value, By Country, 2018-2027 ($ Million)

Table 13 South America Wilms Tumor Treatment Market Value, By Treatment Type, 2018-2027 ($ Million)

Table 14 South America Wilms Tumor Treatment Market Value, By End-Users, 2018-2027 ($ Million)

Table 15 South America Wilms Tumor Treatment Market Value, By Country, 2018-2027 ($ Million)

Table 16 Europe Wilms Tumor Treatment Market Value, By Treatment Type, 2018-2027 ($ Million)

Table 17 Europe Wilms Tumor Treatment Market Value, By End-Users, 2018-2027 ($ Million)

Table 18 Europe Wilms Tumor Treatment Market Value, By Country, 2018-2027 ($ Million)

Table 19 Asia-Pacific Wilms Tumor Treatment Market Value, By Treatment Type, 2018-2027 ($ Million)

Table 20 Asia-Pacific Wilms Tumor Treatment Market Value, By End-Users, 2018-2027 ($ Million)

Table 21 Asia-Pacific Wilms Tumor Treatment Market Value, By Country, 2018-2027 ($ Million)

Table 22 Middle East & Africa Wilms Tumor Treatment Market Value, By Treatment Type, 2018-2027 ($ Million)

Table 23 Middle East & Africa Wilms Tumor Treatment Market Value, By End-Users, 2018-2027 ($ Million)

Table 24 F. Hoffmann-La Roche Ltd: Overview

Table 25 F. Hoffmann-La Roche Ltd: Product Portfolio

Table 26 F. Hoffmann-La Roche Ltd: Key Developments

Table 27 Bayer HealthCare LLC: Overview

Table 28 Bayer HealthCare LLC: Product Portfolio

Table 29 Bayer HealthCare LLC: Key Developments

Table 30 Sanofi Pasteur Inc: Overview

Table 31 Sanofi Pasteur Inc: Product Portfolio

Table 32 Sanofi Pasteur Inc: Key Developments

Table 33 Merck & Co. Inc: Overview

Table 34 Merck & Co. Inc: Product Portfolio

Table 35 Merck & Co. Inc: Key Developments

Table 36 MediLexicon International Ltd: Overview

Table 37 MediLexicon International Ltd: Product Portfolio

Table 38 MediLexicon International Ltd: Key Developments

Table 39 Bristol-Myers Squibb: Overview

Table 40 Bristol-Myers Squibb: Product Portfolio

Table 41 Bristol-Myers Squibb: Key Developments

Table 42 APOTEX Inc: Overview

Table 43 APOTEX Inc: Product Portfolio

Table 44 APOTEX Inc: Key Developments

Table 45 Exelixis Inc: Overview

Table 46 Exelixis Inc: Product Portfolio

Table 47 Exelixis Inc: Key Developments

Table 48 NanoSmart Pharmaceuticals Inc: Overview

Table 49 NanoSmart Pharmaceuticals Inc: Product Portfolio

Table 50 NanoSmart Pharmaceuticals Inc: Key Developments

Table 51 Pfizer Inc: Overview

Table 52 Pfizer Inc: Product Portfolio

Table 53 Pfizer Inc: Key Developments


 

List of Figures

Figure 1 Global Wilms Tumor Treatment Market Share, By Treatment Type, 2019 & 2027 (%)

Figure 2 Global Wilms Tumor Treatment Market Share, By End-Users, 2019 & 2027 (%)

Figure 3 Global Wilms Tumor Treatment Market Share, By Region, 2019 & 2027 (%)

Figure 4 Global Wilms Tumor Treatment Market Value, 2018-2027 ($ Million)

Figure 5 Global Wilms Tumor Treatment Market Y-o-Y Growth, By Treatment Type, 2019-2027 (%)

Figure 6 Surgery: Global Wilms Tumor Treatment Market Value, 2018-2027 ($ Million)

Figure 7 Chemotherapy: Global Wilms Tumor Treatment Market Value, 2018-2027 ($ Million)

Figure 8 Radiation Therapy: Global Wilms Tumor Treatment Market Value, 2018-2027 ($ Million)

Figure 9 Others: Global Wilms Tumor Treatment Market Value, 2018-2027 ($ Million)

Figure 10 Global Wilms Tumor Treatment Market Y-o-Y Growth, By End-Users, 2019-2027 (%)

Figure 11 Hospitals: Global Wilms Tumor Treatment Market Value, 2018-2027 ($ Million)

Figure 12 Cancer Research Institutes: Global Wilms Tumor Treatment Market Value, 2018-2027 ($ Million)

Figure 13 Surgical Centers: Global Wilms Tumor Treatment Market Value, 2018-2027 ($ Million)

Figure 14 Others: Global Wilms Tumor Treatment Market Value, 2018-2027 ($ Million)

Figure 15 Global Wilms Tumor Treatment Market Y-o-Y Growth, By Region, 2019-2027 (%)

Figure 16 North America Wilms Tumor Treatment Market Value, 2018-2027 ($ Million)

Figure 17 North America Wilms Tumor Treatment Market Share, By Treatment Type, 2019 & 2027 (%)

Figure 18 North America Wilms Tumor Treatment Market Share, By End-Users, 2019 & 2027 (%)

Figure 19 North America Wilms Tumor Treatment Market Share, By Country, 2019 & 2027 (%)

Figure 20 South America Wilms Tumor Treatment Market Value, 2018-2027 ($ Million)

Figure 21 South America Wilms Tumor Treatment Market Share, By Treatment Type, 2019 & 2027 (%)

Figure 22 South America Wilms Tumor Treatment Market Share, By End-Users, 2019 & 2027 (%)

Figure 23 South America Wilms Tumor Treatment Market Share, By Country, 2019 & 2027 (%)

Figure 24 Europe Wilms Tumor Treatment Market Value, 2018-2027 ($ Million)

Figure 25 Europe Wilms Tumor Treatment Market Share, By Treatment Type, 2019 & 2027 (%)

Figure 26 Europe Wilms Tumor Treatment Market Share, By End-Users, 2019 & 2027 (%)

Figure 27 Europe Wilms Tumor Treatment Market Share, By Country, 2019 & 2027 (%)

Figure 28 Asia-Pacific Wilms Tumor Treatment Market Value, 2018-2027 ($ Million)

Figure 29 Asia-Pacific Wilms Tumor Treatment Market Share, By Treatment Type, 2019 & 2027 (%)

Figure 30 Asia-Pacific Wilms Tumor Treatment Market Share, By End-Users, 2019 & 2027 (%)

Figure 31 Asia-Pacific Wilms Tumor Treatment Market Share, By Country, 2019 & 2027 (%)

Figure 32 Middle East & Africa Wilms Tumor Treatment Market Value, 2018-2027 ($ Million)

Figure 33 Middle East & Africa Wilms Tumor Treatment Market Share, By Treatment Type, 2019 & 2027 (%)

Figure 34 Middle East & Africa Wilms Tumor Treatment Market Share, By End-Users, 2019 & 2027 (%)

Figure 35 F. Hoffmann-La Roche Ltd: Financials

Figure 36 Bayer HealthCare LLC: Financials

Figure 37 Sanofi Pasteur Inc: Financials

Figure 38 Merck & Co. Inc: Financials

Figure 39 MediLexicon International Ltd: Financials

Figure 40 Bristol-Myers Squibb: Financials

Figure 41 APOTEX Inc: Financials

Figure 42 Exelixis Inc: Financials

Figure 43 NanoSmart Pharmaceuticals Inc: Financials

Figure 44 Pfizer Inc: Financials

Figure 45 Exelixis Inc: Financials

Figure 46 NanoSmart Pharmaceuticals Inc: Financials

Figure 47 Pfizer Inc: Financials

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report



Get your FREE SAMPLE PROPOSAL with a single click!

linkedinpinterest